Logo Boehringer Ingelheim

We are looking for an enthusiastic, highly motivated and creative
Investigative Pathologist in viral-based cancer therapies (f/m/diverse)

ViraTherapeutics is a subsidiary of the Boehringer Ingelheim (BI) group of companies: a perfect symbiosis of big pharma and a biotech start-up vibe. Located in the beautiful city of Innsbruck, Austria - a great place to live and to work - our dedicated Research team develops innovative viral-based immune-oncology treatment options.

We are looking for an enthusiastic, highly motivated and creative

Investigative Pathologist in viral-based cancer therapies (f/m/diverse)

In this science-focused position, you will be an integral driver of a translational science hub de-convoluting early anti-cancer research concepts.

Your role:

  • Advance our histopathological expertise to develop human ex vivo based assays and investigate exploratory biomarkers associated with mechanisms of actions of oncolytic viruses/immunomodulatory therapeutics, in collaboration with the oncology translational science (OTS) group in BI discovery research
  • Set-up and implement basic and new histopathological platforms to drive innovative science and drug discovery, including multiplex assays and digital pathology analyses
  • Actively contribute to the design and pre-clinically validation of tissue-based biomarker assays and drive the development of capabilities of the pathology OTS group
  • Interact and communicate within a highly dynamic external research network including partners from academia, industry and also the local clinical surgery departments (including presentations of the project work at scientific conferences)
  • Train and supervise technical staff

Your ideal qualification:

  • Certified pathologist (MD or DVM) with a profound expertise and scientific curiosity in human cancer etiology, with postdoctoral/clinical experience in cancer biology
  • In depth knowledge and hands-on experience in basic and advanced tissue-based techniques such as routine histology, immunohistochemistry (IHC)/immunofluorescence (IF) (multiplexing), microscopy
  • Experience in Digital Pathology is a strong asset
  • Critical-thinking and trouble-shoot abilities to develop novel cell-based and molecular assays
  • Sound knowledge of cancer immunology, cancer immunotherapy and human based ex vivo assays to foster translation of novel virus based anti-cancer therapeutics is preferred
  • Excellent interpersonal and clear communication skills to integrate in a multi-disciplinary, lively and flexible team
  • Evidence of scientific rigor and excellence as documented by first author peer-reviewed publications
  • Fluency in English, both spoken and written; German language skills would be highly appreciated (otherwise willingness to learn German)

Our offer:

  • You will have the unique possibility to drive research towards a novel cancer therapy at the interface of science and translation being part of an engaged scientific team.
  • Work within the passionate, science-driven atmosphere of a small biotech company whilst at the same time benefit from being part of the global group of Boehringer Ingelheim, one of the pharmaceutical industry’s top 20 companies worldwide.
  • We offer an attractive salary package in line with your qualification, experience and individual competencies.

Contact:
ViraTherapeutics GmbH, Dr. Monika Petersson, Bundesstrasse 27, 6063 Rum, Austria
www.viratherapeutics.com
We look forward to receiving your application by email: jobs@viratherapeutics.com

Back to all vacancies